Introduction
============

Primary neoplasms of the small bowel are quite uncommon, representing only about 3% of all neoplasms of the digestive tract, although the small bowel accounts for more than 90% of the intestinal mucosal surface[@B1]. The clinical symptoms are non-specific. Most small bowel tumours are not diagnosed until complications, such as bleeding, bowel obstruction, or perforation, occur. Other clinical symptoms are lassitude, weight loss, and abdominal pain and discomfort. Neuroendocrine tumours present with symptoms related to their hormonal activity. Carcinoid syndrome is a typical example, and can be characterised by clinically apparent signs that appear late in the disease, when the tumour has already spread to the liver[@B2]. This small index of clinical suspicion makes the detection of small bowel tumours a challenge for all clinicians. Most malignant small bowel tumours have already metastasised when diagnosed, which is responsible for the poor prognosis[@B3].

Radiologists assume a major role in the detection of small bowel tumours. Endoscopy provides the advantage of obtaining biopsies, but only the terminal ileum, the duodenum, and the proximal ileum can be sufficiently explored in routine procedures. Ileoscopy is further compromised by the occasional inability to reach the caecum or to intubate the ileum during colonoscopy. Enteroscopy plays a significant role in the diagnosis of small bowel tumours, but may cover only a limited length of the small intestine and is not commonly available. The push enteroscopy is a promising endoscopic alternative; however, the procedure is time-consuming and complicated and rarely available[@B4],[@B5]. Video capsule endoscopy provides an excellent alternative for the imaging and detection of small bowel disease. To date, definitive results are controversial and video capsule endoscopy is limited by complications, such as the capsule being lost, getting stuck, or by a low battery supply[@B6]. Another limitation of all endoscopic methods is the lack of information about the extramural extent of small bowel tumours.

For many years, 'conventional' double contrast enteroclysis has been suggested as the technique of choice for the evaluation of the small intestine[@B7]. Adequate distension of the small bowel allows imaging of mucosal abnormalities and provides functional information by defining free peristaltic contraction or fixation of the small bowel loops. The principal disadvantage of conventional enteroclysis is the limited information about the state of the bowel wall and extramural extension of tumour disease. Thus, it has largely been replaced by computed tomography (CT).

CT has the advantage of visualising the entire gastrointestinal tract as well as the extramural structures and abdominal organs. The introduction of multidetector-row scanners (MDCT) and advanced three-dimensional imaging capabilities have renewed interest in using CT to detect and stage small bowel tumours[@B8]. The best visualisation of small lesions is achieved with CT enteroclysis. In this method, a negative enteral contrast medium (methylcellulose solution) is administered through a nasojejunal tube, providing small bowel distension and optimal imaging of the small bowel wall[@B9].

CT imaging
==========

Optimal imaging is achieved with the use of multidetector CT (MDCT). The currently available devices, with 16--64 detector rows, allow the acquisition of data sets with near isotropic voxels, which leads to high-resolution imaging and is used for further multiplanar reconstructions (MPR). CT is often the first modality ordered in a patient with suspected obstruction or unclear abdominal symptoms. In cases where a suspected endocrine tumour, such as a carcinoid, is active, the scan protocol should be extended to detect possible hypervascular liver metastases. This provides tumour detection and staging in a one-stop-procedure.

Dedicated small bowel CT is typically requested in patients with known small bowel malignancies or if conventional imaging or endoscopy failed to demonstrate any abnormalities in patients with ongoing clinical symptoms[@B10]. Good results in tumour detection are achieved with CT enteroclysis[@B11],[@B12]. CT enteroclysis is performed in a standardised fashion. After nasojejunal tube placement under fluoroscopic guidance, 1500 ml of 0.5% methylcellulose solution (MCS) are administered via a roller pump at an injection rate of 100--120 ml/min to provide adequate and uniform small bowel distension. Immediately after the administration of the designated or tolerated volume of methylcellulose, patients are transferred from the fluoroscopy suite to the CT unit, where 20 mg of hyoscine-*N*-butylbromide (Buscopan®, Boehringer Ingelheim, Germany) are injected i.v. for minimisation of potential artefacts by peristaltic bowel movement. While lying on the CT table, an additional 500 ml of MCS are administered at a flow rate of 80 ml/min to maintain optimal distension of the upper small jejunal loops during CT examination. CT enterography provides an alternative to CT enteroclysis, when tube placement is not available or has failed. Small bowel distension is achieved after oral application of low-density fluid, mixed with different types of water-binding substances to impair resorption[@B13],[@B14]. CT enterography requires high patient compliance, because a total of 1800--2000 ml of fluid has to be consumed before the CT investigation.

In general, negative oral contrast agents are now given for CT enteroclysis (i.e. methylcellulose) or for CT enterography (i.e. water, methylcellulose, or PEG solution), because they provide better contrast between the low-density lumen and contrast-enhanced tumours of the small bowel. Oral contrast material of high density such as water soluble iodine solution has been suggested as a contrast material to visualise small bowel obstruction[@B15]. However, this approach may impair visualisation of the structure of the small bowel wall.

Suggested CT parameters for a 64-row scanner are as follows: 120 kV, 200 mAs and automatic dose modulation, detector configuration 64 × 0.6 (depending on the device), reconstructed slice thickness/interval of 3/2 mm and 1/0.7 mm for coronal MPR. 120--140 ml of non-ionic contrast material (at 300 mg/ml iodine) can be injected (at 4--5 ml/s) for a single phase scan or a biphasic scan in the arterial and venous phase. For CT enteroclysis and enterography usually a shorter delay of approx. 30--40 s would result in excellent mucosal enhancement. If a tumour is suspected and liver staging is sought, then a biphasic scan in the arterial and venous phase may be advantageous.

Benign tumours
==============

Benign neoplasms account for approximately 1--2% of all GI tract tumours, with leiomyomas and adenomas the most common types of tumours. Other types of benign tumours, such as lipomas and hamartomas, are less frequently encountered[@B15]. Clinical presentation is non-specific, and 50% of patients remain asymptomatic.

Leiomyoma
---------

Leiomyomas originate from the muscle coat of the small intestine and present mostly as solitary lesions. They are the most common benign tumour of the small bowel (with incidences ranging between 22 and 43%) and appear distributed throughout the jejunum and the ileum, with a slight predilection for the jejunum[@B16]. They may be located submucosally, intramurally, or subserosally and appear in CT as a sharply defined spherical mass from 1 cm to 10 cm diameter with homogenous tissue and show uniform contrast enhancement. Larger lesions may display dense focal calcifications. When located submucosally, they may present with small, focal, mucosal pressure ulcers. The typical findings and the absence of mesenteric changes and metastases helps in the diagnosis and mostly rules out malignant differential diagnoses.

Adenoma
-------

Adenomas account for 14--20% of benign small bowel tumours[@B17]. They are proliferative epithelial neoplasms and are further classified like colon adenomas. They appear mainly as tubular adenomatous polyps, although villous adenomas are more common in the small bowel than in the colon. Adenomatous polyps demonstrate as intraluminal masses of small size (less than 2 cm). When multiple, they usually affect a single intestinal segment. In the case of familiar polyposis, the polyps are distributed throughout the entire small intestine. Villous adenomas are slightly larger, with an average diameter of over 3 cm, often broad-based. Adenomas are usually asymptomatic. If pedunculated, they may intussuscept and cause small bowel obstruction.

At CT, adenomas appear as a well-defined soft tissue mass showing moderate enhancement after intravenous contrast application, with clear fat planes around the tumour ([Fig. 1](#F1){ref-type="fig"}). Inflammatory fibroid polyps, predominantly located in the ileum, are an essential consideration in the differential diagnosis. Figure 1Duodenal adenoma. (a) Axial MDCT of a polypoid intraluminal mass (arrow) in the duodenum with distinct contrast enhancement. A fat rim allows good delineation of the bowel wall, there are no signs of bowel wall infiltration. (b) Coronal and (c) sagittal reformation.

Lipoma
------

Lipomas represent the third most common benign lesion of the small intestine (8--20%). They are typically located in the duodenum or distal small bowel and commonly present with intussusceptions or bleeding. They mostly grow in a solitary fashion, and to a large size, then undergo necrosis, cystic degeneration, and calcification[@B18]. On CT, lipomas appear as sharply defined, ovoid masses with fat equivalent attenuation values of −40 to −100 HU. In the case of intussusception of a lipoma, CT can identify the lead point as a mass of fat tissue density ([Fig. 2](#F2){ref-type="fig"}). Figure 2Lipoma of the small intestine. (a) Axial and (b) coronal MDCT images of an intraluminal mass (arrow) in the terminal ileum with fat-equivalent attenuation values.

Haemangioma
-----------

Intestinal haemangiomas are mostly located in the jejunum and usually present with gastrointestinal bleeding. On CT, detection is difficult, unless the haemangioma is a large, well-defined, contrast-enhancing mass within the small bowel wall. Thin-section MPRs can sometimes enable the depiction of a feeding vessel[@B19].

Polyposis syndromes
-------------------

Polyposis syndromes include the Peutz--Jeghers syndrome, Cowden\'s disease, juvenile polyposis, Cronkhite--Canada syndrome, Gardner\'s syndrome, and familial adenomatous polyposis (FAP)[@B20]. The small polyps can be seen as several soft-tissue masses spread throughout the entire small bowel. Smaller lesions are easily detected on CT enteroclysis. In FAP and Gardner\'s syndrome, the polyps may grow in the small intestine after resection of the colon.

Malignant tumours
=================

Up to 70% of all symptomatic small bowel tumours are found to be malignant. Risk factors for the development of malignant small bowel tumours include all forms of inflammatory bowel disease (Crohn\'s and celiac disease), FAP, neurofibromatosis and AIDS. At the time of diagnosis, more than 50% of the malignancies are not amenable to surgical resection, resulting in a very poor prognosis for neoplasms of the GI tract.

Adenocarcinoma
--------------

Adenocarcinoma is documented to be the most common malignant neoplasm of the small intestine, although it represents only 1% of all primary GI malignancies[@B21]. The duodenum is the most frequently involved site, with the proximal jejunum second, primarily in the first 25--30 cm beyond the ligament of Treitz. Adenocarcinoma as a complication of Crohn\'s disease arises mostly in the terminal ileum[@B22].

On CT, adenocarcinoma may have a variable appearance ([Fig. 3](#F3){ref-type="fig"}). It typically appears as a focal wall thickening involving a short segment that causes luminal stenosis and small bowel obstruction ([Fig. 4](#F4){ref-type="fig"}). Mucosal ulceration is typical and can be depicted on CT enteroclysis. CT typically demonstrates heterogeneous attenuation and moderate contrast enhancement. Adenocarcinoma tends to infiltrate the entire bowel wall and to extend into the surrounding mesenteric fat tissue, inciting a local desmoplastic reaction. CT is further valuable for imaging tumour extension, involvement of the adjacent viscera, and to stage distant metastases, focal, or distant lymph node involvement and peritoneal carcinosis. Typically, liver metastases of small bowel adenocarcinomas are seen as low attenuation focal lesions, visualised during the portal venous phase of enhancement[@B23]. Particular findings, such as a solitary lesion, high-grade small bowel obstruction, the involvement of only a short segment, and the rather proximal location, are imaging characteristics that help to differentiate small bowel adenocarcinoma from other small bowel malignancies. Figure 3Duodenal adenocarcinoma. MDCT shows a contrast-enhanced mass of the descending part of the duodenum infiltrating the surrounding mesenterial fat and the pancreas head (arrow). It is difficult to differentiate between duodenal cancer invading the pancreatic head and (the much more common situation of) pancreatic cancer invading the duodenum. Figure 4Duodenal adenocarcinoma (horizontal part). (a) Axial and (b) coronal CT images with contrast-enhanced circumferential wall thickening of the horizontal part of the duodenum (arrow) causing stenosis with prestenotic dilatation, typical for adenocarcinoma.

Neuroendocrine tumours (NET)
----------------------------

Neuroendocrine tumours (NET), formerly known as carcinoids, originate from the enterochromaffine cells at the base of the Lieberkuhn crypts within the bowel wall. After adenocarcinoma, these tumours are the next most frequently found common small bowel malignancies, representing up to 25% of all primary small bowel tumours. NETs are mainly located in the appendix (50%), but 33% can be found in the small bowel with a predilection for the ileum[@B24]. They are slow-growing neoplasms, first appearing as submucosal nodules best detected on CT enteroclysis ([Fig. 5](#F5){ref-type="fig"}a). In later stages, a carcinoid resembles a mural contrast-enhancing mass extending into the adjacent mesentery, causing a soft-tissue density mass, often with spiculated margins due to the desmoplastic reaction. Calcifications are seen in up to 70% ([Fig. 5](#F5){ref-type="fig"}b,c). The desmoplastic reaction is described as surrounding and encasing mesenteric vessels, and, in the worst case, leading to ischaemia of the affected small bowel loop. Early clinical symptoms are rare. Primary tumours are often less than 2 cm in size at diagnosis and may remain asymptomatic until the development of liver metastases, which are responsible for the hormonal activity that causes the carcinoid syndrome. Cutaneous flushing, intermittent hypertension, diarrhoea, and palpitations are the typical symptoms, sometimes induced by alcohol consumption[@B25]. Small bowel obstruction secondary to the desmoplastic reaction is a recognized complication, and mesenteric lymph node enlargement and peritoneal seeding are signs of an advanced tumour stage. The desmoplastic reaction typically occurs with lymph node disease in the mesentery. Liver metastases are typically hypervascular and best demonstrated on arterial phase imaging, appearing as bright, contrast-enhancing masses. A mesenteric soft tissue mass with calcifications, a desmoplastic reaction, and avid contrast enhancement, accompanied by the presence of hypervascular liver metastases, are the characteristic findings of neuroendocrine tumours and should prompt the search for the primary lesion in the bowel. Figure 5Neuroendocrine tumour (NET). (a) Axial MDCT image with contrast-enhanced focal nodular wall thickening of the ileum (arrow); (b) the desmoplastic reaction within the adjacent mesenterial fat with typical calcifications below (arrow); (c) coronal reformation.

Lymphoma
--------

Lymphoma affects the small intestine either as a primary neoplasm that arises focally from the mucosa-associated lymphoid tissue (MALT) or as a part of systemic lymphatic disease. It is described to be the third most common primary malignant tumour of the small intestine, representing 15--20% of all small bowel malignancies. Lymphoma of the small bowel may also occur as a complication of coeliac disease[@B26].

Clinical symptoms are mostly non-specific, and affected patients complain about weight loss, fever, diarrhoea, and non-specific abdominal pain. Lymphoma is typically located in the ileum. On CT, it appears with several growth patterns: multiple contrast-enhancing mucosal nodules that affect the small bowel multifocally or along a segment of several centimetres ([Fig. 6](#F6){ref-type="fig"}); or, a single mass lesion that varies in size, with segmental, contrast-enhancing wall thickening and destruction of the mucosal folds, as well as infiltration into surrounding mesenteric fat. Lymphatic tumours are mostly soft, and are unlikely to cause small bowel obstruction, although luminal narrowing and intussusception can also occur[@B27]. The finding of a rather longer segmental small bowel wall thickening or a mass without severe obstruction located in the more distal part of the small bowel marks the difference between adenocarcinoma and other malignancies. Figure 6Small bowel lymphoma. (a) Segmental wall thickening of an ileal loop (arrow). Typically there are no signs of luminal narrowing. (b) The same lesion on coronal reformation.

Gastrointestinal stroma tumour (GIST)
-------------------------------------

GIST is a common mesenchymal tumour of the gastrointestinal tract, primarily located in the stomach. Some authors consider GIST a benign neoplasm with the potential for malignant transformation, but most authors definitely classify GIST as a malignant tumour of the GI tract. It arises from the smooth mussel cells within the small bowel wall and, if not located in the stomach, mostly occurs in the jejunum[@B28]. Pathologically, GIST can be classified as benign, borderline, low, or highly malignant. Unless obvious metastases are present, there are no reliable CT signs in imaging to distinguish malignant from benign GIST. Therefore, surgical resection of a suspected GIST lesion is recommended. On CT, GIST typically appears as an exophytic, sometimes bulky mass, with moderate contrast enhancement, and tends to show central necrosis and calcification. Tumours can extend to a size of several centimetres, displacing the adjacent bowel loops, making the origin of the tumour difficult to appreciate ([Figs. 7](#F7){ref-type="fig"}, [8](#F8){ref-type="fig"}). In the case of malignancy, GIST typically causes liver metastases and peritoneal seeding. Liver metastases mostly appear as hypoattenuating lesions. Figure 7Gastrointestinal stroma tumour (GIST). (a) A contrast-enhanced ileal mass in the lower abdomen, infiltrating into the mesenteric fat (arrow). Adjacent to the mass, there are small extraluminal air bubbles as a sign of perforation; mesenteric stranding indicates local peritonitis. (b) Coronal reformation and small mesenteric lymph nodes. Figure 8Low grade GIST of the jejunum. (a) Axial and (b) coronal MDCT images of another patient with a large rim-enhanced mass in the jejunum histologically verified as low grade GIST.

Leiomyosarcoma
--------------

This malignant neoplasm arises from the intestinal smooth muscle of the bowel wall or the small intestinal blood vessels and accounts for less than 15% of primary intestinal malignancies. As a rule, leiomyosarcomas present as a single lesion and are located in the jejunum and ileum, but most commonly in a Meckel\'s diverticulum. Tumours grow slowly and predominantly extraluminally and the onset of clinical symptoms (i.e., bowel obstruction) is late.

On CT images, leiomyosarcomas appear primarily as large heterogeneous masses, with central necrosis and cystic portions, and show a typical rim enhancement after contrast administration ([Fig. 9](#F9){ref-type="fig"}) Leiomyosarcomas may also be associated with ulceration, cavitation, or fistula[@B29]. CT also can depict liver and peritoneal metastases, which are typically large and necrotic with rim enhancement. Figure 9Leiomyosarcoma of the small bowel. (a,b) Axial MDCT images of the lower abdomen with segmental contrast-enhanced wall thickening, histologically verified as a leiomyosarcoma. The tumour is mostly located intraluminal; distinct perifocal stranding suggests mesenteric infiltration.

Metastases
----------

Metastases of the small bowel can be caused by intraperitoneal seeding, direct extension from adjacent tumours, or by haematogenous spread[@B30]. Colon and ovarian carcinoma are the most frequent site of origin of intraperitoneal metastases that can affect the small bowel wall. Typical CT findings are small contrast-enhancing nodules along the serosal surface. In advanced disease, these nodules encase the small bowel and cause obstruction ([Fig. 10](#F10){ref-type="fig"}). Advanced stages of pancreatic, biliary, or colonic malignancies tend to infiltrate adjacent small bowel loops. Figure 10Peritoneal carcinomatosis. (a,b) Extensive peritoneal seeding in a patient with end-stage ovarian carcinoma. There are multifocal contrast enhancing nodular masses infiltrating the small bowel wall and the ventral abdominal wall.

Haematogenous metastases commonly originate from bronchial carcinoma, breast carcinoma, melanoma, and renal cell carcinoma. There are no pathognomonic findings for any metastases, but, typically, they present as short, segmental, contrast-enhancing, wall thickening or as masses, causing transient intussusception or ulceration with bleeding ([Fig. 11](#F11){ref-type="fig"}). Figure 11Small bowel metastasis. (a) Axial and (b) coronal CT images of a large mass in the left lower part of the abdomen. Small central air bubbles are the only sign of an intestinal origin. The mass was verified as a metastasis of a seminoma.

Conclusion
==========

The detection of neoplasms of the small intestine poses a significant diagnostic challenge to both clinician and radiologist. The diagnosis is affected by the low incidence of small bowel tumours and the mostly late onset of clinical symptoms. Due to the limitations of capsule endoscopy to assess the small bowel in patients with suspected obstruction, the high-resolution images provided by 64-row MDCT, in combination with the technique of CT enteroclysis or enterography, have renewed interest in using CT for small bowel tumour detection. The appearance, the typical locations, and the different propensity to seed metastases allow the spectrum of differential diagnoses to be narrowed (see [Table 1](#T1){ref-type="table"}). Radiologists, therefore, should be familiar with the CT appearance of various intestinal neoplasms. Table 1Differential diagnosis of the most common malignant primary small bowel neoplasmsLocationTypical signsAdenocarcinomaDuodenum, proximal jejunumShort segment affected; high-grade small bowel obstructionCarcinoidIleum (appendix)Desmoplastic reaction mesentery; calcification; hypervascular liver metastasesLymphomaIleumLong segment affected; luminal narrowing without small bowel obstruction; lymphadenopathyMalignant GISTJejunum (stomach)Large mass, exophytic; central necrosis; calcificationLeiomyosarcomaJejunum, ileum, Meckel\'s diverticulumSolitary large mass; cavitation, ulceration, fistula
